United Therapeutics Corporation
United Therapeutics Corporation UTHR Peers
See (UTHR) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| UTHR | $324.20 | -0.39% | 14.6B | 12.92 | $25.09 | N/A |
| VRTX | $446.50 | +0.24% | 114.7B | -117.50 | -$3.80 | N/A |
| REGN | $487.86 | -0.60% | 51.8B | 12.39 | $39.36 | +0.36% |
| SGEN | $228.74 | -0.07% | 43.2B | -57.19 | -$4.00 | N/A |
| ALNY | $303.73 | -0.77% | 39.6B | -144.63 | -$2.10 | N/A |
| ARGX | $576.61 | -1.37% | 35.2B | 35.20 | $16.38 | N/A |
| BNTX | $115.62 | +2.23% | 27.8B | -32.30 | -$3.58 | N/A |
| BGNE | $184.71 | +0.49% | 20.2B | -22.55 | -$8.19 | N/A |
| DNA-WT | $0.27 | -2.76% | 18.7B | N/A | N/A | N/A |
| RPRX | $33.29 | +0.09% | 18.7B | 13.59 | $2.45 | +2.58% |
Stock Comparison
UTHR vs VRTX Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, VRTX has a market cap of 114.7B. Regarding current trading prices, UTHR is priced at $324.20, while VRTX trades at $446.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas VRTX's P/E ratio is -117.50. In terms of profitability, UTHR's ROE is +0.19%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, UTHR is less volatile compared to VRTX. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs REGN Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, REGN has a market cap of 51.8B. Regarding current trading prices, UTHR is priced at $324.20, while REGN trades at $487.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas REGN's P/E ratio is 12.39. In terms of profitability, UTHR's ROE is +0.19%, compared to REGN's ROE of +0.15%. Regarding short-term risk, UTHR is less volatile compared to REGN. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs SGEN Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, SGEN has a market cap of 43.2B. Regarding current trading prices, UTHR is priced at $324.20, while SGEN trades at $228.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas SGEN's P/E ratio is -57.19. In terms of profitability, UTHR's ROE is +0.19%, compared to SGEN's ROE of -0.21%. Regarding short-term risk, UTHR is more volatile compared to SGEN. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs ALNY Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, ALNY has a market cap of 39.6B. Regarding current trading prices, UTHR is priced at $324.20, while ALNY trades at $303.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas ALNY's P/E ratio is -144.63. In terms of profitability, UTHR's ROE is +0.19%, compared to ALNY's ROE of -5.09%. Regarding short-term risk, UTHR is more volatile compared to ALNY. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs ARGX Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, ARGX has a market cap of 35.2B. Regarding current trading prices, UTHR is priced at $324.20, while ARGX trades at $576.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas ARGX's P/E ratio is 35.20. In terms of profitability, UTHR's ROE is +0.19%, compared to ARGX's ROE of +0.16%. Regarding short-term risk, UTHR is less volatile compared to ARGX. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs BNTX Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, BNTX has a market cap of 27.8B. Regarding current trading prices, UTHR is priced at $324.20, while BNTX trades at $115.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas BNTX's P/E ratio is -32.30. In terms of profitability, UTHR's ROE is +0.19%, compared to BNTX's ROE of -0.04%. Regarding short-term risk, UTHR is less volatile compared to BNTX. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs BGNE Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, BGNE has a market cap of 20.2B. Regarding current trading prices, UTHR is priced at $324.20, while BGNE trades at $184.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas BGNE's P/E ratio is -22.55. In terms of profitability, UTHR's ROE is +0.19%, compared to BGNE's ROE of -0.12%. Regarding short-term risk, UTHR is more volatile compared to BGNE. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs DNA-WT Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, DNA-WT has a market cap of 18.7B. Regarding current trading prices, UTHR is priced at $324.20, while DNA-WT trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas DNA-WT's P/E ratio is N/A. In terms of profitability, UTHR's ROE is +0.19%, compared to DNA-WT's ROE of -0.63%. Regarding short-term risk, UTHR is less volatile compared to DNA-WT. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs RPRX Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, RPRX has a market cap of 18.7B. Regarding current trading prices, UTHR is priced at $324.20, while RPRX trades at $33.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas RPRX's P/E ratio is 13.59. In terms of profitability, UTHR's ROE is +0.19%, compared to RPRX's ROE of +0.16%. Regarding short-term risk, UTHR is more volatile compared to RPRX. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs SMMT Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, SMMT has a market cap of 15.2B. Regarding current trading prices, UTHR is priced at $324.20, while SMMT trades at $20.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas SMMT's P/E ratio is -60.65. In terms of profitability, UTHR's ROE is +0.19%, compared to SMMT's ROE of -0.70%. Regarding short-term risk, UTHR is less volatile compared to SMMT. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs GMAB Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, GMAB has a market cap of 13.2B. Regarding current trading prices, UTHR is priced at $324.20, while GMAB trades at $21.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas GMAB's P/E ratio is 12.56. In terms of profitability, UTHR's ROE is +0.19%, compared to GMAB's ROE of +0.26%. Regarding short-term risk, UTHR is less volatile compared to GMAB. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs INCY Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, INCY has a market cap of 13B. Regarding current trading prices, UTHR is priced at $324.20, while INCY trades at $67.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas INCY's P/E ratio is 335.65. In terms of profitability, UTHR's ROE is +0.19%, compared to INCY's ROE of +0.01%. Regarding short-term risk, UTHR is less volatile compared to INCY. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs KRTX Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, KRTX has a market cap of 12.6B. Regarding current trading prices, UTHR is priced at $324.20, while KRTX trades at $329.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas KRTX's P/E ratio is -28.09. In terms of profitability, UTHR's ROE is +0.19%, compared to KRTX's ROE of -0.36%. Regarding short-term risk, UTHR is more volatile compared to KRTX. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs EXEL Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, EXEL has a market cap of 11.6B. Regarding current trading prices, UTHR is priced at $324.20, while EXEL trades at $42.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas EXEL's P/E ratio is 19.48. In terms of profitability, UTHR's ROE is +0.19%, compared to EXEL's ROE of +0.29%. Regarding short-term risk, UTHR is less volatile compared to EXEL. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs BMRN Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, BMRN has a market cap of 10.9B. Regarding current trading prices, UTHR is priced at $324.20, while BMRN trades at $56.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas BMRN's P/E ratio is 21.03. In terms of profitability, UTHR's ROE is +0.19%, compared to BMRN's ROE of +0.09%. Regarding short-term risk, UTHR is less volatile compared to BMRN. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs MRNA Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, MRNA has a market cap of 10.8B. Regarding current trading prices, UTHR is priced at $324.20, while MRNA trades at $27.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas MRNA's P/E ratio is -3.19. In terms of profitability, UTHR's ROE is +0.19%, compared to MRNA's ROE of -0.30%. Regarding short-term risk, UTHR is less volatile compared to MRNA. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs ASND Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, ASND has a market cap of 10.5B. Regarding current trading prices, UTHR is priced at $324.20, while ASND trades at $174.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas ASND's P/E ratio is -26.71. In terms of profitability, UTHR's ROE is +0.19%, compared to ASND's ROE of +1.91%. Regarding short-term risk, UTHR is less volatile compared to ASND. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs RXDX Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, RXDX has a market cap of 9.6B. Regarding current trading prices, UTHR is priced at $324.20, while RXDX trades at $199.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas RXDX's P/E ratio is -56.47. In terms of profitability, UTHR's ROE is +0.19%, compared to RXDX's ROE of -0.31%. Regarding short-term risk, UTHR is more volatile compared to RXDX. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs IMGN Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, IMGN has a market cap of 8.7B. Regarding current trading prices, UTHR is priced at $324.20, while IMGN trades at $31.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas IMGN's P/E ratio is -111.55. In terms of profitability, UTHR's ROE is +0.19%, compared to IMGN's ROE of -1.43%. Regarding short-term risk, UTHR is more volatile compared to IMGN. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs BPMC Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, BPMC has a market cap of 8.2B. Regarding current trading prices, UTHR is priced at $324.20, while BPMC trades at $127.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas BPMC's P/E ratio is -50.84. In terms of profitability, UTHR's ROE is +0.19%, compared to BPMC's ROE of -0.49%. Regarding short-term risk, UTHR is more volatile compared to BPMC. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs CERE Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, CERE has a market cap of 8.2B. Regarding current trading prices, UTHR is priced at $324.20, while CERE trades at $44.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas CERE's P/E ratio is -16.47. In terms of profitability, UTHR's ROE is +0.19%, compared to CERE's ROE of -0.43%. Regarding short-term risk, UTHR is more volatile compared to CERE. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs ROIVW Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, ROIVW has a market cap of 7.8B. Regarding current trading prices, UTHR is priced at $324.20, while ROIVW trades at $2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas ROIVW's P/E ratio is -0.67. In terms of profitability, UTHR's ROE is +0.19%, compared to ROIVW's ROE of -0.02%. Regarding short-term risk, UTHR is less volatile compared to ROIVW. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs ROIV Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, ROIV has a market cap of 7.6B. Regarding current trading prices, UTHR is priced at $324.20, while ROIV trades at $11.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas ROIV's P/E ratio is -15.00. In terms of profitability, UTHR's ROE is +0.19%, compared to ROIV's ROE of -0.02%. Regarding short-term risk, UTHR is more volatile compared to ROIV. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs TECH Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, TECH has a market cap of 7.6B. Regarding current trading prices, UTHR is priced at $324.20, while TECH trades at $48.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas TECH's P/E ratio is 58.77. In terms of profitability, UTHR's ROE is +0.19%, compared to TECH's ROE of +0.06%. Regarding short-term risk, UTHR is less volatile compared to TECH. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs RVMD Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, RVMD has a market cap of 7.6B. Regarding current trading prices, UTHR is priced at $324.20, while RVMD trades at $40.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas RVMD's P/E ratio is -10.12. In terms of profitability, UTHR's ROE is +0.19%, compared to RVMD's ROE of -0.37%. Regarding short-term risk, UTHR is less volatile compared to RVMD. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs CORT Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, CORT has a market cap of 7.4B. Regarding current trading prices, UTHR is priced at $324.20, while CORT trades at $69.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas CORT's P/E ratio is 60.45. In terms of profitability, UTHR's ROE is +0.19%, compared to CORT's ROE of +0.20%. Regarding short-term risk, UTHR is less volatile compared to CORT. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs VRNA Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, VRNA has a market cap of 7.2B. Regarding current trading prices, UTHR is priced at $324.20, while VRNA trades at $84.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas VRNA's P/E ratio is -42.40. In terms of profitability, UTHR's ROE is +0.19%, compared to VRNA's ROE of -0.90%. Regarding short-term risk, UTHR is less volatile compared to VRNA. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs BBIO Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, BBIO has a market cap of 7.1B. Regarding current trading prices, UTHR is priced at $324.20, while BBIO trades at $37.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas BBIO's P/E ratio is -10.54. In terms of profitability, UTHR's ROE is +0.19%, compared to BBIO's ROE of +0.49%. Regarding short-term risk, UTHR is less volatile compared to BBIO. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs JAZZ Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, JAZZ has a market cap of 6.8B. Regarding current trading prices, UTHR is priced at $324.20, while JAZZ trades at $110.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas JAZZ's P/E ratio is 14.99. In terms of profitability, UTHR's ROE is +0.19%, compared to JAZZ's ROE of +0.12%. Regarding short-term risk, UTHR is less volatile compared to JAZZ. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs HALO Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, HALO has a market cap of 6.6B. Regarding current trading prices, UTHR is priced at $324.20, while HALO trades at $53.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas HALO's P/E ratio is 14.18. In terms of profitability, UTHR's ROE is +0.19%, compared to HALO's ROE of +1.22%. Regarding short-term risk, UTHR is less volatile compared to HALO. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs RETA Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, RETA has a market cap of 6.6B. Regarding current trading prices, UTHR is priced at $324.20, while RETA trades at $172.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas RETA's P/E ratio is -66.29. In terms of profitability, UTHR's ROE is +0.19%, compared to RETA's ROE of +0.47%. Regarding short-term risk, UTHR is more volatile compared to RETA. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs MDGL Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, MDGL has a market cap of 6.3B. Regarding current trading prices, UTHR is priced at $324.20, while MDGL trades at $284.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas MDGL's P/E ratio is -15.94. In terms of profitability, UTHR's ROE is +0.19%, compared to MDGL's ROE of -0.51%. Regarding short-term risk, UTHR is less volatile compared to MDGL. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs TGTX Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, TGTX has a market cap of 5.8B. Regarding current trading prices, UTHR is priced at $324.20, while TGTX trades at $36.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas TGTX's P/E ratio is 145.64. In terms of profitability, UTHR's ROE is +0.19%, compared to TGTX's ROE of +0.19%. Regarding short-term risk, UTHR is less volatile compared to TGTX. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs TLX Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, TLX has a market cap of 5.7B. Regarding current trading prices, UTHR is priced at $324.20, while TLX trades at $16.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas TLX's P/E ratio is 188.56. In terms of profitability, UTHR's ROE is +0.19%, compared to TLX's ROE of +0.14%. Regarding short-term risk, UTHR is less volatile compared to TLX. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs NUVL Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, NUVL has a market cap of 5.6B. Regarding current trading prices, UTHR is priced at $324.20, while NUVL trades at $78.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas NUVL's P/E ratio is -17.69. In terms of profitability, UTHR's ROE is +0.19%, compared to NUVL's ROE of -0.31%. Regarding short-term risk, UTHR is less volatile compared to NUVL. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs IONS Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, IONS has a market cap of 5.5B. Regarding current trading prices, UTHR is priced at $324.20, while IONS trades at $34.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas IONS's P/E ratio is -11.63. In terms of profitability, UTHR's ROE is +0.19%, compared to IONS's ROE of -0.92%. Regarding short-term risk, UTHR is less volatile compared to IONS. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs ABCM Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, ABCM has a market cap of 5.5B. Regarding current trading prices, UTHR is priced at $324.20, while ABCM trades at $23.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas ABCM's P/E ratio is 2399.00. In terms of profitability, UTHR's ROE is +0.19%, compared to ABCM's ROE of -0.01%. Regarding short-term risk, UTHR is more volatile compared to ABCM. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs ISEE Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, ISEE has a market cap of 5.5B. Regarding current trading prices, UTHR is priced at $324.20, while ISEE trades at $39.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas ISEE's P/E ratio is -22.44. In terms of profitability, UTHR's ROE is +0.19%, compared to ISEE's ROE of -0.39%. Regarding short-term risk, UTHR is more volatile compared to ISEE. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs AXSM Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, AXSM has a market cap of 5.4B. Regarding current trading prices, UTHR is priced at $324.20, while AXSM trades at $110.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas AXSM's P/E ratio is -19.09. In terms of profitability, UTHR's ROE is +0.19%, compared to AXSM's ROE of -3.64%. Regarding short-term risk, UTHR is less volatile compared to AXSM. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs ALKS Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, ALKS has a market cap of 5.2B. Regarding current trading prices, UTHR is priced at $324.20, while ALKS trades at $31.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas ALKS's P/E ratio is 14.89. In terms of profitability, UTHR's ROE is +0.19%, compared to ALKS's ROE of +0.25%. Regarding short-term risk, UTHR is more volatile compared to ALKS. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs ADMA Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, ADMA has a market cap of 4.9B. Regarding current trading prices, UTHR is priced at $324.20, while ADMA trades at $20.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas ADMA's P/E ratio is 24.36. In terms of profitability, UTHR's ROE is +0.19%, compared to ADMA's ROE of +0.72%. Regarding short-term risk, UTHR is less volatile compared to ADMA. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs PCVX Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, PCVX has a market cap of 4.5B. Regarding current trading prices, UTHR is priced at $324.20, while PCVX trades at $34.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas PCVX's P/E ratio is -8.69. In terms of profitability, UTHR's ROE is +0.19%, compared to PCVX's ROE of -0.17%. Regarding short-term risk, UTHR is less volatile compared to PCVX. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs ALPN Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, ALPN has a market cap of 4.5B. Regarding current trading prices, UTHR is priced at $324.20, while ALPN trades at $64.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas ALPN's P/E ratio is -101.52. In terms of profitability, UTHR's ROE is +0.19%, compared to ALPN's ROE of -0.04%. Regarding short-term risk, UTHR is more volatile compared to ALPN. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs MRUS Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, MRUS has a market cap of 4.3B. Regarding current trading prices, UTHR is priced at $324.20, while MRUS trades at $62.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas MRUS's P/E ratio is -15.00. In terms of profitability, UTHR's ROE is +0.19%, compared to MRUS's ROE of -0.41%. Regarding short-term risk, UTHR is less volatile compared to MRUS. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs OPT Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, OPT has a market cap of 4.2B. Regarding current trading prices, UTHR is priced at $324.20, while OPT trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas OPT's P/E ratio is -1.52. In terms of profitability, UTHR's ROE is +0.19%, compared to OPT's ROE of +2.60%. Regarding short-term risk, UTHR is more volatile compared to OPT. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs RYTM Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, RYTM has a market cap of 4.2B. Regarding current trading prices, UTHR is priced at $324.20, while RYTM trades at $65.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas RYTM's P/E ratio is -23.45. In terms of profitability, UTHR's ROE is +0.19%, compared to RYTM's ROE of -1.80%. Regarding short-term risk, UTHR is less volatile compared to RYTM. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs RNA Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, RNA has a market cap of 4.1B. Regarding current trading prices, UTHR is priced at $324.20, while RNA trades at $34.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas RNA's P/E ratio is -11.47. In terms of profitability, UTHR's ROE is +0.19%, compared to RNA's ROE of -0.27%. Regarding short-term risk, UTHR is less volatile compared to RNA. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs AKRO Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, AKRO has a market cap of 4.1B. Regarding current trading prices, UTHR is priced at $324.20, while AKRO trades at $51.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas AKRO's P/E ratio is -13.78. In terms of profitability, UTHR's ROE is +0.19%, compared to AKRO's ROE of -0.32%. Regarding short-term risk, UTHR is less volatile compared to AKRO. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs MRTX Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, MRTX has a market cap of 4.1B. Regarding current trading prices, UTHR is priced at $324.20, while MRTX trades at $58.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas MRTX's P/E ratio is -4.82. In terms of profitability, UTHR's ROE is +0.19%, compared to MRTX's ROE of -0.62%. Regarding short-term risk, UTHR is more volatile compared to MRTX. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs PTCT Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, PTCT has a market cap of 4B. Regarding current trading prices, UTHR is priced at $324.20, while PTCT trades at $50.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas PTCT's P/E ratio is 7.79. In terms of profitability, UTHR's ROE is +0.19%, compared to PTCT's ROE of -0.72%. Regarding short-term risk, UTHR is less volatile compared to PTCT. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs SLNO Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, SLNO has a market cap of 3.9B. Regarding current trading prices, UTHR is priced at $324.20, while SLNO trades at $77.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas SLNO's P/E ratio is -16.32. In terms of profitability, UTHR's ROE is +0.19%, compared to SLNO's ROE of -0.78%. Regarding short-term risk, UTHR is less volatile compared to SLNO. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs CYTK Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, CYTK has a market cap of 3.8B. Regarding current trading prices, UTHR is priced at $324.20, while CYTK trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas CYTK's P/E ratio is -6.05. In terms of profitability, UTHR's ROE is +0.19%, compared to CYTK's ROE of +8.01%. Regarding short-term risk, UTHR is less volatile compared to CYTK. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs SRPT Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, SRPT has a market cap of 3.8B. Regarding current trading prices, UTHR is priced at $324.20, while SRPT trades at $38.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas SRPT's P/E ratio is -14.73. In terms of profitability, UTHR's ROE is +0.19%, compared to SRPT's ROE of -0.20%. Regarding short-term risk, UTHR is less volatile compared to SRPT. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs KRYS Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, KRYS has a market cap of 3.8B. Regarding current trading prices, UTHR is priced at $324.20, while KRYS trades at $131.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas KRYS's P/E ratio is 31.42. In terms of profitability, UTHR's ROE is +0.19%, compared to KRYS's ROE of +0.14%. Regarding short-term risk, UTHR is less volatile compared to KRYS. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs RYZB Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, RYZB has a market cap of 3.8B. Regarding current trading prices, UTHR is priced at $324.20, while RYZB trades at $62.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas RYZB's P/E ratio is -57.86. In terms of profitability, UTHR's ROE is +0.19%, compared to RYZB's ROE of +0.83%. Regarding short-term risk, UTHR is more volatile compared to RYZB. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs CBAY Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, CBAY has a market cap of 3.7B. Regarding current trading prices, UTHR is priced at $324.20, while CBAY trades at $32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas CBAY's P/E ratio is -32.81. In terms of profitability, UTHR's ROE is +0.19%, compared to CBAY's ROE of -0.64%. Regarding short-term risk, UTHR is more volatile compared to CBAY. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs ACAD Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, ACAD has a market cap of 3.7B. Regarding current trading prices, UTHR is priced at $324.20, while ACAD trades at $21.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas ACAD's P/E ratio is 16.04. In terms of profitability, UTHR's ROE is +0.19%, compared to ACAD's ROE of +0.35%. Regarding short-term risk, UTHR is less volatile compared to ACAD. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs ACLX Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, ACLX has a market cap of 3.6B. Regarding current trading prices, UTHR is priced at $324.20, while ACLX trades at $65.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas ACLX's P/E ratio is -21.79. In terms of profitability, UTHR's ROE is +0.19%, compared to ACLX's ROE of -0.35%. Regarding short-term risk, UTHR is less volatile compared to ACLX. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs SWTX Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, SWTX has a market cap of 3.5B. Regarding current trading prices, UTHR is priced at $324.20, while SWTX trades at $46.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas SWTX's P/E ratio is -13.70. In terms of profitability, UTHR's ROE is +0.19%, compared to SWTX's ROE of -0.51%. Regarding short-term risk, UTHR is more volatile compared to SWTX. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs RARE Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, RARE has a market cap of 3.4B. Regarding current trading prices, UTHR is priced at $324.20, while RARE trades at $36.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas RARE's P/E ratio is -6.24. In terms of profitability, UTHR's ROE is +0.19%, compared to RARE's ROE of -1.86%. Regarding short-term risk, UTHR is less volatile compared to RARE. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs CRSP Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, CRSP has a market cap of 3.3B. Regarding current trading prices, UTHR is priced at $324.20, while CRSP trades at $38.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas CRSP's P/E ratio is -8.47. In terms of profitability, UTHR's ROE is +0.19%, compared to CRSP's ROE of -0.20%. Regarding short-term risk, UTHR is less volatile compared to CRSP. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs PTGX Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, PTGX has a market cap of 3.2B. Regarding current trading prices, UTHR is priced at $324.20, while PTGX trades at $51.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas PTGX's P/E ratio is 65.45. In terms of profitability, UTHR's ROE is +0.19%, compared to PTGX's ROE of +0.09%. Regarding short-term risk, UTHR is less volatile compared to PTGX. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs MLTX Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, MLTX has a market cap of 3.1B. Regarding current trading prices, UTHR is priced at $324.20, while MLTX trades at $48.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas MLTX's P/E ratio is -21.17. In terms of profitability, UTHR's ROE is +0.19%, compared to MLTX's ROE of -0.00%. Regarding short-term risk, UTHR is less volatile compared to MLTX. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs MTSR Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, MTSR has a market cap of 3.1B. Regarding current trading prices, UTHR is priced at $324.20, while MTSR trades at $29.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas MTSR's P/E ratio is -11.59. In terms of profitability, UTHR's ROE is +0.19%, compared to MTSR's ROE of -0.63%. Regarding short-term risk, UTHR is less volatile compared to MTSR. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs CPRX Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, CPRX has a market cap of 3B. Regarding current trading prices, UTHR is priced at $324.20, while CPRX trades at $24.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas CPRX's P/E ratio is 15.86. In terms of profitability, UTHR's ROE is +0.19%, compared to CPRX's ROE of +0.28%. Regarding short-term risk, UTHR is less volatile compared to CPRX. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs CRNX Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, CRNX has a market cap of 3B. Regarding current trading prices, UTHR is priced at $324.20, while CRNX trades at $32.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas CRNX's P/E ratio is -8.45. In terms of profitability, UTHR's ROE is +0.19%, compared to CRNX's ROE of -0.31%. Regarding short-term risk, UTHR is less volatile compared to CRNX. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs VKTX Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, VKTX has a market cap of 3B. Regarding current trading prices, UTHR is priced at $324.20, while VKTX trades at $26.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas VKTX's P/E ratio is -22.94. In terms of profitability, UTHR's ROE is +0.19%, compared to VKTX's ROE of -0.14%. Regarding short-term risk, UTHR is less volatile compared to VKTX. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs SRRK Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, SRRK has a market cap of 2.9B. Regarding current trading prices, UTHR is priced at $324.20, while SRRK trades at $30.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas SRRK's P/E ratio is -12.13. In terms of profitability, UTHR's ROE is +0.19%, compared to SRRK's ROE of -1.18%. Regarding short-term risk, UTHR is less volatile compared to SRRK. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs MORF Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, MORF has a market cap of 2.9B. Regarding current trading prices, UTHR is priced at $324.20, while MORF trades at $56.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas MORF's P/E ratio is -14.88. In terms of profitability, UTHR's ROE is +0.19%, compared to MORF's ROE of -0.22%. Regarding short-term risk, UTHR is more volatile compared to MORF. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs MOR Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, MOR has a market cap of 2.9B. Regarding current trading prices, UTHR is priced at $324.20, while MOR trades at $18.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas MOR's P/E ratio is -12.64. In terms of profitability, UTHR's ROE is +0.19%, compared to MOR's ROE of +2.51%. Regarding short-term risk, UTHR is less volatile compared to MOR. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs KYMR Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, KYMR has a market cap of 2.8B. Regarding current trading prices, UTHR is priced at $324.20, while KYMR trades at $43.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas KYMR's P/E ratio is -14.01. In terms of profitability, UTHR's ROE is +0.19%, compared to KYMR's ROE of -0.30%. Regarding short-term risk, UTHR is less volatile compared to KYMR. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs KDNY Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, KDNY has a market cap of 2.7B. Regarding current trading prices, UTHR is priced at $324.20, while KDNY trades at $40.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas KDNY's P/E ratio is -12.47. In terms of profitability, UTHR's ROE is +0.19%, compared to KDNY's ROE of -0.41%. Regarding short-term risk, UTHR is more volatile compared to KDNY. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs IMVT Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, IMVT has a market cap of 2.6B. Regarding current trading prices, UTHR is priced at $324.20, while IMVT trades at $15.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas IMVT's P/E ratio is -5.65. In terms of profitability, UTHR's ROE is +0.19%, compared to IMVT's ROE of -0.81%. Regarding short-term risk, UTHR is less volatile compared to IMVT. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs MYOV Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, MYOV has a market cap of 2.6B. Regarding current trading prices, UTHR is priced at $324.20, while MYOV trades at $26.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas MYOV's P/E ratio is -14.05. In terms of profitability, UTHR's ROE is +0.19%, compared to MYOV's ROE of +0.50%. Regarding short-term risk, UTHR is more volatile compared to MYOV. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs LEGN Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, LEGN has a market cap of 2.6B. Regarding current trading prices, UTHR is priced at $324.20, while LEGN trades at $28.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas LEGN's P/E ratio is -24.09. In terms of profitability, UTHR's ROE is +0.19%, compared to LEGN's ROE of -0.20%. Regarding short-term risk, UTHR is less volatile compared to LEGN. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs AAPG Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, AAPG has a market cap of 2.5B. Regarding current trading prices, UTHR is priced at $324.20, while AAPG trades at $27.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas AAPG's P/E ratio is -37.50. In terms of profitability, UTHR's ROE is +0.19%, compared to AAPG's ROE of -2.50%. Regarding short-term risk, UTHR is less volatile compared to AAPG. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs IBRX Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, IBRX has a market cap of 2.4B. Regarding current trading prices, UTHR is priced at $324.20, while IBRX trades at $2.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas IBRX's P/E ratio is -4.75. In terms of profitability, UTHR's ROE is +0.19%, compared to IBRX's ROE of +0.65%. Regarding short-term risk, UTHR is less volatile compared to IBRX. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs PRVB Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, PRVB has a market cap of 2.4B. Regarding current trading prices, UTHR is priced at $324.20, while PRVB trades at $24.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas PRVB's P/E ratio is -16.43. In terms of profitability, UTHR's ROE is +0.19%, compared to PRVB's ROE of +1.33%. Regarding short-term risk, UTHR is more volatile compared to PRVB. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs APLS Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, APLS has a market cap of 2.4B. Regarding current trading prices, UTHR is priced at $324.20, while APLS trades at $18.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas APLS's P/E ratio is -10.45. In terms of profitability, UTHR's ROE is +0.19%, compared to APLS's ROE of -1.00%. Regarding short-term risk, UTHR is less volatile compared to APLS. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs XENE Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, XENE has a market cap of 2.4B. Regarding current trading prices, UTHR is priced at $324.20, while XENE trades at $30.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas XENE's P/E ratio is -9.54. In terms of profitability, UTHR's ROE is +0.19%, compared to XENE's ROE of -0.32%. Regarding short-term risk, UTHR is less volatile compared to XENE. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs NAMSW Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, NAMSW has a market cap of 2.4B. Regarding current trading prices, UTHR is priced at $324.20, while NAMSW trades at $8.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas NAMSW's P/E ratio is N/A. In terms of profitability, UTHR's ROE is +0.19%, compared to NAMSW's ROE of -0.33%. Regarding short-term risk, UTHR is less volatile compared to NAMSW. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs LBPH Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, LBPH has a market cap of 2.3B. Regarding current trading prices, UTHR is priced at $324.20, while LBPH trades at $59.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas LBPH's P/E ratio is -26.66. In terms of profitability, UTHR's ROE is +0.19%, compared to LBPH's ROE of -0.33%. Regarding short-term risk, UTHR is more volatile compared to LBPH. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs BCRX Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, BCRX has a market cap of 2.3B. Regarding current trading prices, UTHR is priced at $324.20, while BCRX trades at $11.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas BCRX's P/E ratio is -43.04. In terms of profitability, UTHR's ROE is +0.19%, compared to BCRX's ROE of +0.11%. Regarding short-term risk, UTHR is less volatile compared to BCRX. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs ARWR Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, ARWR has a market cap of 2.3B. Regarding current trading prices, UTHR is priced at $324.20, while ARWR trades at $16.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas ARWR's P/E ratio is -13.39. In terms of profitability, UTHR's ROE is +0.19%, compared to ARWR's ROE of -0.47%. Regarding short-term risk, UTHR is less volatile compared to ARWR. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs DICE Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, DICE has a market cap of 2.3B. Regarding current trading prices, UTHR is priced at $324.20, while DICE trades at $47.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas DICE's P/E ratio is -21.91. In terms of profitability, UTHR's ROE is +0.19%, compared to DICE's ROE of +0.56%. Regarding short-term risk, UTHR is more volatile compared to DICE. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs MIRM Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, MIRM has a market cap of 2.2B. Regarding current trading prices, UTHR is priced at $324.20, while MIRM trades at $45.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas MIRM's P/E ratio is -28.13. In terms of profitability, UTHR's ROE is +0.19%, compared to MIRM's ROE of -0.34%. Regarding short-term risk, UTHR is less volatile compared to MIRM. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs APGE Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, APGE has a market cap of 2.2B. Regarding current trading prices, UTHR is priced at $324.20, while APGE trades at $37.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas APGE's P/E ratio is -10.27. In terms of profitability, UTHR's ROE is +0.19%, compared to APGE's ROE of -0.19%. Regarding short-term risk, UTHR is less volatile compared to APGE. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs CALT Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, CALT has a market cap of 2.1B. Regarding current trading prices, UTHR is priced at $324.20, while CALT trades at $40.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas CALT's P/E ratio is -22.73. In terms of profitability, UTHR's ROE is +0.19%, compared to CALT's ROE of -1.67%. Regarding short-term risk, UTHR is less volatile compared to CALT. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs KNSA Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, KNSA has a market cap of 2.1B. Regarding current trading prices, UTHR is priced at $324.20, while KNSA trades at $29.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas KNSA's P/E ratio is -121.29. In terms of profitability, UTHR's ROE is +0.19%, compared to KNSA's ROE of -0.04%. Regarding short-term risk, UTHR is less volatile compared to KNSA. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs BLTE Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, BLTE has a market cap of 2.1B. Regarding current trading prices, UTHR is priced at $324.20, while BLTE trades at $64.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas BLTE's P/E ratio is -47.31. In terms of profitability, UTHR's ROE is +0.19%, compared to BLTE's ROE of -0.31%. Regarding short-term risk, UTHR is more volatile compared to BLTE. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs NAMS Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, NAMS has a market cap of 2.1B. Regarding current trading prices, UTHR is priced at $324.20, while NAMS trades at $18.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas NAMS's P/E ratio is -10.15. In terms of profitability, UTHR's ROE is +0.19%, compared to NAMS's ROE of -0.33%. Regarding short-term risk, UTHR is less volatile compared to NAMS. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs VCEL Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, VCEL has a market cap of 2.1B. Regarding current trading prices, UTHR is priced at $324.20, while VCEL trades at $41.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas VCEL's P/E ratio is 831.40. In terms of profitability, UTHR's ROE is +0.19%, compared to VCEL's ROE of +0.01%. Regarding short-term risk, UTHR is less volatile compared to VCEL. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs VCYT Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, VCYT has a market cap of 2.1B. Regarding current trading prices, UTHR is priced at $324.20, while VCYT trades at $26.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas VCYT's P/E ratio is 63.10. In terms of profitability, UTHR's ROE is +0.19%, compared to VCYT's ROE of +0.03%. Regarding short-term risk, UTHR is less volatile compared to VCYT. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs CGON Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, CGON has a market cap of 2B. Regarding current trading prices, UTHR is priced at $324.20, while CGON trades at $26.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas CGON's P/E ratio is -17.87. In terms of profitability, UTHR's ROE is +0.19%, compared to CGON's ROE of -0.17%. Regarding short-term risk, UTHR is less volatile compared to CGON. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs HRMY Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, HRMY has a market cap of 2B. Regarding current trading prices, UTHR is priced at $324.20, while HRMY trades at $35.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas HRMY's P/E ratio is 13.47. In terms of profitability, UTHR's ROE is +0.19%, compared to HRMY's ROE of +0.24%. Regarding short-term risk, UTHR is less volatile compared to HRMY. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs DNLI Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, DNLI has a market cap of 2B. Regarding current trading prices, UTHR is priced at $324.20, while DNLI trades at $13.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas DNLI's P/E ratio is -5.22. In terms of profitability, UTHR's ROE is +0.19%, compared to DNLI's ROE of -0.36%. Regarding short-term risk, UTHR is less volatile compared to DNLI. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs LGND Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, LGND has a market cap of 2B. Regarding current trading prices, UTHR is priced at $324.20, while LGND trades at $102.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas LGND's P/E ratio is -14.04. In terms of profitability, UTHR's ROE is +0.19%, compared to LGND's ROE of -0.16%. Regarding short-term risk, UTHR is more volatile compared to LGND. This indicates potentially higher risk in terms of short-term price fluctuations for UTHR.
UTHR vs VERA Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, VERA has a market cap of 2B. Regarding current trading prices, UTHR is priced at $324.20, while VERA trades at $30.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas VERA's P/E ratio is -10.30. In terms of profitability, UTHR's ROE is +0.19%, compared to VERA's ROE of -0.41%. Regarding short-term risk, UTHR is less volatile compared to VERA. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.
UTHR vs IMCR Comparison
UTHR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UTHR stands at 14.6B. In comparison, IMCR has a market cap of 1.9B. Regarding current trading prices, UTHR is priced at $324.20, while IMCR trades at $38.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UTHR currently has a P/E ratio of 12.92, whereas IMCR's P/E ratio is -90.07. In terms of profitability, UTHR's ROE is +0.19%, compared to IMCR's ROE of -0.06%. Regarding short-term risk, UTHR is less volatile compared to IMCR. This indicates potentially lower risk in terms of short-term price fluctuations for UTHR.